Literature DB >> 8358706

Clostridium difficile: clinical disease and diagnosis.

F C Knoop1, M Owens, I C Crocker.   

Abstract

Clostridium difficile is an opportunistic pathogen that causes a spectrum of disease ranging from antibiotic-associated diarrhea to pseudomembranous colitis. Although the disease was first described in 1893, the etiologic agent was not isolated and identified until 1978. Since clinical and pathological features of C. difficile-associated disease are not easily distinguished from those of other gastrointestinal diseases, including ulcerative colitis, chronic inflammatory bowel disease, and Crohn's disease, diagnostic methods have relied on either isolation and identification of the microorganism or direct detection of bacterial antigens or toxins in stool specimens. The current review focuses on the sensitivity, specificity, and practical use of several diagnostic tests, including methods for culture of the etiologic agent, cellular cytotoxicity assays, latex agglutination tests, enzyme immunoassay systems, counterimmunoelectrophoresis, fluorescent-antibody assays, and polymerase chain reactions.

Entities:  

Mesh:

Year:  1993        PMID: 8358706      PMCID: PMC358285          DOI: 10.1128/CMR.6.3.251

Source DB:  PubMed          Journal:  Clin Microbiol Rev        ISSN: 0893-8512            Impact factor:   26.132


  249 in total

1.  Comparative study of immunological properties and cytotoxic effects of Clostridium difficile toxin B and Clostridium sordellii toxin L.

Authors:  O Baldacini; R Girardot; G A Green; B Rihn; H Monteil
Journal:  Toxicon       Date:  1992-02       Impact factor: 3.033

Review 2.  Antimicrobial agent-induced diarrhea--a bacterial disease.

Authors:  W L George; V L Sutter; S M Finegold
Journal:  J Infect Dis       Date:  1977-12       Impact factor: 5.226

3.  Multicenter evaluation of a new enzyme immunoassay for detection of Clostridium difficile enterotoxin A.

Authors:  P C De Girolami; P A Hanff; K Eichelberger; L Longhi; H Teresa; J Pratt; A Cheng; J M Letourneau; G M Thorne
Journal:  J Clin Microbiol       Date:  1992-05       Impact factor: 5.948

4.  Biological activities of toxins A and B of Clostridium difficile.

Authors:  D M Lyerly; D E Lockwood; S H Richardson; T D Wilkins
Journal:  Infect Immun       Date:  1982-03       Impact factor: 3.441

5.  Experimental reproduction of neonatal diarrhea in young gnotobiotic hares simultaneously associated with Clostridium difficile and other Clostridium strains.

Authors:  J Dabard; F Dubos; L Martinet; R Ducluzeau
Journal:  Infect Immun       Date:  1979-04       Impact factor: 3.441

6.  Colitis induced by Clostridium difficile.

Authors:  J G Bartlett; T Chang; N S Taylor; A B Onderdonk
Journal:  Rev Infect Dis       Date:  1979 Mar-Apr

7.  Clostridium difficile in normal infants and sudden infant death syndrome: an association with infant formula feeding.

Authors:  M S Cooperstock; E Steffen; R Yolken; A Onderdonk
Journal:  Pediatrics       Date:  1982-07       Impact factor: 7.124

8.  Detection of Clostridium difficile in faeces by direct gas liquid chromatography.

Authors:  P N Levett
Journal:  J Clin Pathol       Date:  1984-02       Impact factor: 3.411

9.  The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile.

Authors:  N S Ambrose; M Johnson; D W Burdon; M R Keighley
Journal:  J Antimicrob Chemother       Date:  1985-03       Impact factor: 5.790

10.  Enzyme immunoassay (ELISA) for detection of Clostridium difficile toxin B in specimens of faeces.

Authors:  V K Nguyen; B Rihn; C Heckel; F Bisseret; R Girardot; H Monteil
Journal:  J Med Microbiol       Date:  1990-04       Impact factor: 2.472

View more
  34 in total

1.  Evaluation of two rapid assays for detection of Clostridium difficile toxin A in stool specimens.

Authors:  D P Fedorko; H D Engler; E M O'Shaughnessy; E C Williams; C J Reichelderfer; W I Smith
Journal:  J Clin Microbiol       Date:  1999-09       Impact factor: 5.948

Review 2.  Drug-induced Clostridium difficile-associated disease.

Authors:  M L Job; N F Jacobs
Journal:  Drug Saf       Date:  1997-07       Impact factor: 5.606

3.  Diarrhoea developing in hospital patients.

Authors:  R M McLoughlin; H J O'Connor
Journal:  Ir J Med Sci       Date:  2005 Jan-Mar       Impact factor: 1.568

4.  Rho proteins play a critical role in cell migration during the early phase of mucosal restitution.

Authors:  M F Santos; S A McCormack; Z Guo; J Okolicany; Y Zheng; L R Johnson; G Tigyi
Journal:  J Clin Invest       Date:  1997-07-01       Impact factor: 14.808

5.  Safety and immunogenicity of increasing doses of a Clostridium difficile toxoid vaccine administered to healthy adults.

Authors:  K L Kotloff; S S Wasserman; G A Losonsky; W Thomas; R Nichols; R Edelman; M Bridwell; T P Monath
Journal:  Infect Immun       Date:  2001-02       Impact factor: 3.441

6.  Evaluation of three commercial enzyme immunoassay kits for detecting faecal Clostridium difficile toxins.

Authors:  S A Arrow; L Croese; R A Bowman; T V Riley
Journal:  J Clin Pathol       Date:  1994-10       Impact factor: 3.411

7.  Application of isothermal helicase-dependent amplification with a disposable detection device in a simple sensitive stool test for toxigenic Clostridium difficile.

Authors:  Wing Huen A Chow; Cindy McCloskey; Yanhong Tong; Lin Hu; Qimin You; Ciarán P Kelly; Huimin Kong; Yi-Wei Tang; Wen Tang
Journal:  J Mol Diagn       Date:  2008-07-31       Impact factor: 5.568

8.  Rapid detection of Clostridium difficile in feces by real-time PCR.

Authors:  Simon D Bélanger; Maurice Boissinot; Natalie Clairoux; François J Picard; Michel G Bergeron
Journal:  J Clin Microbiol       Date:  2003-02       Impact factor: 5.948

9.  [Antibiotic induced diarrhea and pseudomembranous colitis].

Authors:  C Greb; T Kalem; T Kälble
Journal:  Urologe A       Date:  2002-12-19       Impact factor: 0.639

10.  Molecular analysis of the pathogenicity locus and polymorphism in the putative negative regulator of toxin production (TcdC) among Clostridium difficile clinical isolates.

Authors:  Patrizia Spigaglia; Paola Mastrantonio
Journal:  J Clin Microbiol       Date:  2002-09       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.